Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

Paolo Antonio Ascierto; E Simeone; V Chiarion Sileni; P Queirolo; M Del Vecchio; L Di Guardo; M Guidoboni; P Marchetti; GC Antonini Cappellini; PF Ferrucci; F Cognetti; MG Bernengo; M Guida; R Marconcini; M Mandalà; C Cimminiello; G Rinaldi; M Aglietta; L Calabrò; M Maio

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

【24h】

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

机译：ipilimumab和BRAF抑制剂对转移性黑色素瘤患者的序贯治疗：来自意大利ipilimumab扩展访问计划（EAP）的数据

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2013年第s1期|共页
作者
Paolo Antonio Ascierto; E Simeone; V Chiarion Sileni; P Queirolo; M Del Vecchio; L Di Guardo; M Guidoboni; P Marchetti; GC Antonini Cappellini; PF Ferrucci; F Cognetti; MG Bernengo; M Guida; R Marconcini; M Mandalà; C Cimminiello; G Rinaldi; M Aglietta; L Calabrò; M Maio;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP) [J] . Paolo Antonio Ascierto, E Simeone, V Chiarion Sileni, Journal for ImmunoTherapy of Cancer . 2013,第S1期

机译：ipilimumab和BRAF抑制剂对转移性黑色素瘤患者的序贯治疗：来自意大利ipilimumab扩展访问计划（EAP）的数据
2. Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program [J] . Ascierto Paolo Antonio, Simeone Ester, Sileni Vanna Chiarion, Cancer investigation . 2014,第1a10期

机译：依匹莫单抗和BRAF抑制剂对转移性黑色素瘤患者的序贯治疗：依匹莫单抗扩大访问计划意大利队列的数据
3. Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy [J] . Caitlyn N. Myrdal, Srinath Sundararajan Case Reports in Oncological Medicine . 2020,第3期

机译：对Ipilimumab / Nivolumab重新检查和BRAF抑制剂/ MEK抑制剂在患者中重新检查，所述患者预先用BRAF靶向治疗和免疫治疗治疗
4. PROTEOMIC PROFILING OF MELANOMA CELL LINES AND TISSUE USING DATA INDEPENDENT ACQUISITION MASS SPECTROMETRY TO PREDICT TREATMENT RESPONSE AND PATIENT SURVIVAL [C] . Christoph Krisp, Robert Parker, Dana Pascovici, International Mass Spectrometry Conference . 2018

机译：黑色素瘤细胞系和组织的蛋白质组学分析使用数据无关的采集质谱来预测治疗反应和患者存活
5. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP) [O] . Paolo Antonio Ascierto, E Simeone, V Chiarion Sileni, 2013

机译：ipilimumab和BRAF抑制剂对转移性黑色素瘤患者的序贯治疗：来自意大利ipilimumab扩展访问计划（EAP）的数据
6. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP) [O] . Paolo Ascierto, E Simeone, V Sileni, 2013

机译：ipilimumab和BRAF抑制剂对转移性黑色素瘤患者的序贯治疗：来自意大利ipilimumab扩展访问计划（EAP）的数据

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)

著录项

相似文献

相关主题

期刊订阅